Julia Koerner

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Endothelial Cells

Replacement Therapy

Prostate Cancer

Inflammatory Response

Top Venues

Nature communications

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Emma G M Tondeur, Jane S A Voerman, Mitchell A A Geleijnse, Laure S van Hofwegen, Anneloes van Krimpen, Julia Koerner, Gunja Mishra, Ziye Song, Christopher Schliehe
Sec22b and Stx4 Depletion Has No Major Effect on Cross-Presentation of PLGA Microsphere-Encapsulated Antigen and a Synthetic Long Peptide In Vitro. Journal of immunology (Baltimore, Md. : 1950) (2023)
Julia Koerner, Dennis Horvath, Franziska Oliveri, Jun Li, Michael Basler
Suppression of prostate cancer and amelioration of the immunosuppressive tumor microenvironment through selective immunoproteasome inhibition. Oncoimmunology 12 (1) (2022)
Julia Koerner, Dennis Horvath, Franziska Oliveri, Jun Li, Michael Basler
Suppression of prostate cancer and amelioration of the immunosuppressive tumor microenvironment through selective immunoproteasome inhibition. Oncoimmunology 12 (1) (2022)
Julia Koerner, Dennis Horvath, Franziska Oliveri, Jun Li, Michael Basler
Suppression of prostate cancer and amelioration of the immunosuppressive tumor microenvironment through selective immunoproteasome inhibition. Oncoimmunology 12 (1) (2022)
Julia Koerner, Dennis Horvath, Franziska Oliveri, Jun Li, Michael Basler
Suppression of prostate cancer and amelioration of the immunosuppressive tumor microenvironment through selective immunoproteasome inhibition. Oncoimmunology 12 (1) (2022)
Julia Koerner, Dennis Horvath, Valerie L Herrmann, Anna MacKerracher, Bruno Gander, Hideo Yagita, Jacques Rohayem, Marcus Groettrup
PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy. Nature communications 12 (1) (2021)